Federal Supply Schedule 36F79726D025E
Award Date 2/1/26
Last Date to Order 7/31/26
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Pricing Type
Fixed Price with Economic Price Adjustment
Legislative Mandate
Not listed National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed Similar IDVs
- The Federal Supply Schedule (FSS) contract award is for DRUGS, PHARMACEUTICALS,&HEMATOLOGY RELATED PRODUCTS (65 I B) on behalf of the Veterans Integrated Service Network 12, a civilian federal agency. The $51,322,640.00 ceiling value contract was awarded on July 1, 2020 to Assertio Therapeutics Inc., a for-profit manufacturer, with a period of performance through October 14, 2025. This multiple award contract provides federal agencies access to a variety of pharmaceutical products and...
- This Federal Supply Schedule contract represents an interim agreement under General Services Administration Schedule 65, Section I, Part B, establishing a multiple-award vehicle for the procurement of drugs, pharmaceuticals, and hematology-related products. The contract was awarded to Scienture, LLC (UEI: S6TXBDG33E17) on November 15, 2025, with an ultimate completion date of May 14, 2026. The contract carries a ceiling value of $25,000.00 and was issued without a set-aside restriction,...
- This Federal Supply Schedule contract represents a multiple-award indefinite delivery vehicle between the Veterans Integrated Service Network 12 (VISN 12), a civilian component of the Veterans Health Administration, and Ars Pharmaceuticals Operations, Inc. (UEI: SNGVNTVBBV57). Awarded on March 15, 2025, the contract falls under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB), specifically addressing drugs, pharmaceuticals, and hematology-related products. The contract...
- This Federal Supply Schedule contract represents a multiple-award indefinite delivery vehicle established between the Veterans Integrated Service Network 12 (VISN 12), a civilian agency component of the Department of Veterans Affairs, and Covis Pharmaceuticals, Inc. (UEI: TK4NNKDSYS31). The contract was awarded on July 1, 2017, under GSA Schedule 61-IB (Pharmaceuticals and Drugs) with a ceiling value of $1,132,470.00 and an ultimate completion date of June 30, 2026. The contract encompasses...
- This Federal Supply Schedule contract was awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian U.S. federal agency, to Spectrum Pharmaceuticals, Inc., a for-profit manufacturer. The contract, with a ceiling value of $25,000.00, is for the delivery of drugs, pharmaceuticals, and hematology-related products under Schedule 65 I B of the Federal Supply Schedule. The contract period of performance extends from the award date of December 16, 2022 to the ultimate completion...
- This Federal Supply Schedule contract awards a multiple-award indefinite delivery vehicle to WG Critical Care, LLC (UEI: KPSBV7269E81) under the General Services Administration's Pharmaceuticals and Drugs schedule (FSS-61-IB). The contract was awarded on June 15, 2024, with an ultimate completion date of June 14, 2029, establishing a five-year performance period. The contract carries a ceiling value of $16,124,000 and is funded through the Veterans Integrated Service Network (VISN) 12, a...
- This Federal Supply Schedule (FSS) contract is a multiple award agreement between the Veterans Integrated Service Network 12 (VISN 12), a civilian entity within the Department of Veterans Affairs, and Syndax Pharmaceuticals, Inc. (UEI: EVTDQKWL8AS5) for the provision of drugs, pharmaceuticals, and hematology-related products under General Services Administration (GSA) schedule 61-IB. The contract was awarded on August 1, 2025, with a ceiling value of $225,000 and an ultimate completion date of...
- The Federal Supply Schedule contract is awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency of the U.S. federal government. The contract, valued up to $1,155,030.00, has an ultimate completion date of August 31, 2029 and was awarded to Soleva Pharma LLC, a for-profit limited liability company, on September 1, 2024. The contract is for the procurement of 65 I B, DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS for VISN 12. As a Federal Supply Schedule...
- Legacy Pharma USA, Inc. was awarded a Multiple Award Federal Supply Schedule contract under General Services Administration (GSA) Schedule 61-IB (Pharmaceuticals and Drugs) effective September 15, 2023, with an ultimate completion date of September 14, 2028. The contract, which carries a ceiling value of $6.15 million, was awarded without a set-aside restriction to provide pharmaceutical and hematology-related products to the Veterans Integrated Service Network 12 (VISN 12), a civilian agency...
- This Federal Supply Schedule contract represents an interim agreement under General Services Administration (GSA) Schedule 65, Section I-B, establishing a multiple-award vehicle for the procurement of drugs, pharmaceuticals, and hematology-related products. Mesoblast, Inc. (UEI: NNVGHSW7VLM7) was awarded this contract by the Veterans Integrated Service Network 12, a civilian component of the Department of Veterans Affairs, on August 18, 2025. The contract carries a ceiling value of $25,000 and...